thiazoles has been researched along with Carcinoma, Epidermoid in 126 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (18.25) | 18.7374 |
| 1990's | 10 (7.94) | 18.2507 |
| 2000's | 38 (30.16) | 29.6817 |
| 2010's | 52 (41.27) | 24.3611 |
| 2020's | 3 (2.38) | 2.80 |
| Authors | Studies |
|---|---|
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Chen, JH; Chuang, FC; Hwang, TZ; Su, YC; Wang, CC; Yeh, SA | 1 |
| Ali, T; Bergamaschi, D; Boehm, K; Celik, S; El Hasnaouy, M; Harwood, CA; Kafaei Golahmadi, D; Kaffa, A; Leigh, IM; Lyu, Y; Maffucci, T; Mannella, V; Mirza, AN | 1 |
| Bu, LL; Deng, WW; Kulkarni, AB; Li, YC; Liu, B; Liu, JF; Mao, L; Sun, ZJ; Wu, L; Yu, GT; Zhang, L; Zhang, WF; Zhao, ZL | 1 |
| Chen, H; Chen, L; Du, J; Li, Q; Pan, J; Qi, H; Shi, X; Zhang, L; Zhong, M | 1 |
| Bai, WL; Ji, WY; Song, Y; Sun, X | 1 |
| Ahn, JC; Biswas, R; Chung, PS; Lee, YK; Mondal, A | 1 |
| Chae, JI; Cho, JH; Jeon, YJ; Ko, SM; Shim, JH | 1 |
| Altavilla, G; Arrigo, C; Di Mirto, C; Mondello, P; Pitini, V | 1 |
| Hu, J; Li, C; Li, H; Li, L; Mei, X; Ren, F; Weng, Z; Wu, M; Zhang, H; Zhao, Y | 1 |
| Bai, A; Bielawska, A; Bielawski, J; Boppana, NB; Breen, P; Gudz, TI; Joseph, N; Korbelik, M; Kraveka, JM; Li, L; Pierce, JS; Rahmaniyan, M; Separovic, D; Van Buren, E | 1 |
| Brunner, AM; Costa, DB; Garcia, E; Hammerman, PS; Heist, RS; Johnson, BE; Lindeman, NI; Oxnard, GR; Sholl, LM | 1 |
| Cai, J; Dai, S; Liu, J; Liu, Z; Lu, J; Ma, J; Qin, Q; Sun, X; Tao, G; Xu, L; Yang, X; Zhan, L; Zhang, C; Zhang, X; Zhu, H; Zuo, Y | 1 |
| Bussink, J; Grénman, R; Iida, M; Kaanders, JH; Peeters, WJ; Span, PN; Stegeman, H; van der Kogel, AJ; Verheijen, MM; Wheeler, DL | 1 |
| Chang, CC; Chang, JM; Chuang, SH; Huang, JJ; Huang, LY; Kao, KJ; Lau, JY; Lee, YS; Lin, HS; Liu, CW; Tsai, PY; Tsai, YJ | 1 |
| Chen, CC; Huang, LY; Huang, WC; Lin, YC; Lin, YT; Wei, TT; Wu, MH | 1 |
| Chang, YC; Hu, FW; Lee, SS; Tsai, LL; Yu, CC; Yu, CH | 1 |
| Alexander, M; Cekanova, M; Rathore, K | 1 |
| Bowlt, K; Mellett, S; Murphy, S; Verganti, S | 1 |
| Brockhoff, G; Doescher, J; Haug, A; Mißlbeck, M; Pickhard, A; Piontek, G; Reiter, R; Rudelius, M; Schiefler, C; Schuettler, D | 1 |
| Chen, C; Du, Q; Gao, W; Hou, L; Hui, Z; Su, B; Sun, Y; Xie, H; Xu, Y; Zhang, P; Zhou, X | 1 |
| Bi, Y; Chen, C; Chen, G; Chen, L; Chen, W; Chen, X; Cheng, C; Cheng, L; Cheng, X; Cui, H; Cui, Y; Dong, B; Gao, Z; Guo, J; Guo, Y; He, M; Hu, X; Huang, X; Jia, Z; Kong, P; Li, B; Li, E; Li, G; Li, H; Li, L; Li, Q; Li, X; Li, Y; Liang, J; Lin, D; Liu, J; Liu, L; Luo, L; Ma, J; Ou, Y; Shi, R; Song, B; Song, Y; Tan, Y; Wan, S; Wang, F; Wang, J; Wang, M; Xi, Y; Xia, Z; Xie, S; Xu, E; Xu, L; Yang, B; Yang, H; Yang, J; Yang, X; Zhan, Q; Zhang, L; Zhang, X; Zhang, Y; Zhao, J; Zhao, Z; Zhou, Y; Zhuang, X | 1 |
| Chen, J; Dong, L; Fu, M; Hou, J; Kang, N; Lan, T; Liu, B; Liu, K; Zhan, Q; Zhang, C; Zhang, W | 1 |
| Baselga, J; Benzaken, AO; Bivona, TG; Brook, S; Chen, Y; Das, R; Elkabets, M; Ghossein, RA; Gurski, JM; Huang, A; Juric, D; Kerr, DA; Liang, J; Liu, M; Morse, N; Pazarentzos, E; Pelossof, RA; Rodon, J; Rosell, R; Rosen, N; Scaltriti, M; Sheng, Q; Tam, A; Teixidó, C; Wang, H; Yan, JJ | 1 |
| Alfieri, RR; Ardizzoni, A; Bonelli, MA; Caffarra, C; Cavazzoni, A; Cretella, D; Falco, A; Frati, C; Fumarola, C; Galetti, M; La Monica, S; Lagrasta, CA; Madeddu, D; Petronini, PG; Quaini, F; Rossetti, P; Saccani, F; Tiseo, M | 1 |
| Ammanangi, R; Bhat, K; Katti, S; Shivpuje, P | 1 |
| Brands, RC; Hartmann, S; Herbst, F; Kübler, AC; Linz, C; Müller-Richter, UDA; Seher, A | 1 |
| Bu, LL; Gutkind, JS; Huang, CF; Kulkarni, AB; Liu, B; Liu, JF; Ma, SR; Sun, ZJ; Yu, GT; Zhang, L; Zhang, WF; Zhao, ZL | 1 |
| Gavard, J; Tjioe, KC; Tostes Oliveira, D | 1 |
| Fukazawa, T; Ibaragi, S; Kurio, N; Masui, M; Matsumoto, K; Nagatsuka, H; Naomoto, Y; Okui, T; Sasaki, A; Shimo, T; Takabatake, K | 1 |
| Fukuda, S; Inamura, N; Kimura, T; Nishihara, H; Tanaka, S; Tanino, M; Tsuda, M; Wang, L; Yanagi, H | 1 |
| Baselga, J; Brook, S; Haimovitz-Friedman, A; Healey, JH; Heller, DA; Humm, JL; Mizrachi, A; Powell, SN; Rajasekhar, VK; Scaltriti, M; Shah, J; Shamay, Y; Soong, J | 1 |
| Chen, HQ; Feng, G; He, J; Hu, J; Wang, DZ | 1 |
| Fujimura, T; Harada, S; Hattori, T; Miwa, K; Oba, M; Ohta, T; Oyama, K; Sasaki, S | 1 |
| Gallick, G; Johnson, FM; Parikh, N; Saigal, B; Sen, B | 1 |
| Ando, Y; Hatori, M; Ito, D; Kurihara, Y; Shintani, S; Tanaka, M; Toyoshima, T | 1 |
| Al-Wadei, HA; Schuller, HM | 1 |
| Berger, W; Dornetshuber, R; Heffeter, P; Hoda, MA; Jungwirth, U; Kiss, R; Mijatovic, T | 1 |
| Chang, FR; Hou, YY; Hwang, YC; Wu, CC; Wu, ML; Wu, YC | 1 |
| Meng, X; Wuyi, L; Xinming, C; Yuhong, X | 1 |
| Gan, YH; Zhang, S | 1 |
| Ding, X; Li, P; Liu, FY; Sun, CF; Zhao, ZJ; Zong, ZH | 1 |
| Bility, MT; Gonzalez, FJ; Kang, BH; Peters, JM; Zhu, B | 1 |
| Berretta, S; Buscarino, C; Del Fabro, V; Di Raimondo, F; Giallongo, C; Massimino, M; Messina, A; Pennisi, MS; Restuccia, N; Stagno, F; Stella, S; Tibullo, D; Tirrò, E; Vigneri, P | 1 |
| Chen, MK; Chen, PN; Chu, SC; Hsieh, YH; Hsieh, YS; Kao, TY; Su, SC; Yang, JS; Yang, SF; Zavras, AI | 1 |
| Gerster, K; Gilbert, R; Ito, E; Liu, FF; Ng, B; Shi, W; Waldron, J; Yue, S | 1 |
| Dunn, EF; Iida, M; Li, C; Wheeler, DL | 1 |
| Chinn, SB; Hochstim, C; Masood, R; Schorn, VJ; Sinha, UK; Zhu, S | 1 |
| Johnson, FM; Peng, S; Saigal, B; Sen, B; Williams, MD | 1 |
| Ma, Y; Wang, H; Ye, F; Zhang, DY; Zhang, F | 1 |
| Camacho-Alonso, F; Gómez-Garcia, F; López-Jornet, P | 1 |
| Bekele, BN; Brooks, HD; Culotta, KS; El-Naggar, A; Ginsberg, LE; Glisson, BS; Johnson, FM; Papadimitrakopoulou, VA; Takebe, N; Tran, HT; Wright, J | 1 |
| Li, SS; Wang, F; Wang, XH; Xuan, XY; Zhang, HY; Zheng, XZ | 1 |
| Fan, X; Guo, B; Guo, W; Jiang, Y; Li, K; Liang, S; Qin, S; Wang, L; Wang, R; Zhao, Y | 1 |
| Chen, X; Huang, HZ; Liu, M; Ma, HB; Tang, HK; Wang, C; Zhang, B | 1 |
| Brunton, VG; Canel, M; Frame, MC; Graham, K; Kinnaird, A; McLeod, K; Serrels, A | 1 |
| Cen, J; Feng, YD; Huang, WL; Li, YM; Yang, Y; Zhang, YY; Zhu, YL | 1 |
| Knecht, R; Kurzweg, T; Laban, S; Möckelmann, N | 1 |
| Bednash, JS; Chiosea, SI; Grandis, JR; Morariu, EM; Otte, CG; Seethala, RR; Wheeler, SE | 1 |
| Chen, CC; Chen, KF; Cheng, AL; Chuang, SH; Lin, YC; Wei, TT; Wu, MH | 1 |
| Dalirsani, Z; Farajnia, S; Javadzadeh, Y; Koozegari, S; Mehdipour, M | 1 |
| Ang, KK; Glisson, B; Johnson, FM; Milas, L; Molkentine, DP; Molkentine, JM; Raju, U; Riesterer, O; Wang, ZQ | 1 |
| An, N; Andrukhov, O; Matejka, M; Rausch-fan, X; Schedle, A; Wieland, M | 1 |
| Brugnera, A; da Silva, PS; de Vieira, AL; do Nascliento, SC; Pinheiro, AL; Rolim, AB | 1 |
| Hamburger, AW; Hebert, C; Nikitakis, NG; Reynolds, MA; Sauk, JJ; Siavash, H | 1 |
| Almahmeed, T; Boyle, JO; Cohen, EG; Dannenberg, AJ; Du, B; Golijanin, D; Soslow, RA; Subbaramaiah, K | 1 |
| Azuma, Y; Date, M; Fukuchi, K; Ohura, K; Shinohara, M; Takahashi, H | 1 |
| Gooding, WE; Grandis, JR; Li, M; Lui, VW; Niwa, H; Wentzel, AL | 1 |
| Chen, YC; Hsu, KC; Ko, CH; Shen, SC | 1 |
| Hattori, T; Kumagai, H; Miwa, K; Mukaisho, K; Sugihara, H; Yamamoto, G | 1 |
| Imagawa, Y; Kimura, S; Satake, K; Tsukuda, M | 1 |
| Bielawski, J; Day, TA; Hannun, YA; Jazwinski, SM; Jiang, JC; Koybasi, S; Obeid, LM; Ogretmen, B; Osta, W; Senkal, CE; Spassieva, S; Sundararaj, K | 1 |
| Bauer, JA; Bradford, CR; Carey, TE; Fisher, SG; Ji, M; Narayan, A; O'Connell, KM; Oliver, CL; Ubell, ML; Wang, S; Wolter, KG; Wu, X | 1 |
| Fujita, S; Nakamura, M; Nakatani, K; Seki, N; Tanzawa, H; Uzawa, K; Wada, T | 1 |
| Bai, R; Dettin, LE; Glazer, RI; Kopelovich, L; Kopleovich, L; Kozikowski, AP; Russell, RG; Wei, ZL; Yin, Y | 1 |
| Chakrabarti, R; Cohen, AN; LoTempio, MM; Ramalingam, TS; Ramamurthy, B; Srivatsan, ES; Steele, HL; Veena, MS; Wang, MB | 1 |
| Chow, KC; Lu, MP; Wu, MT | 1 |
| Li, JR; Li, ZB; Shang, ZJ | 1 |
| Han, W; Hu, Q; Hua, Z; Huang, X; Li, S; Tian, W; Wang, Z | 1 |
| Kong, SK; Kwok, TT; Tsang, WP | 1 |
| Aguila, D; Choi, B; Ebert, O; Genden, EM; Shin, EJ; Wanna, GB; Woo, SL | 1 |
| Siu, LL | 1 |
| Drew, PA; Jamieson, GG; Liu, JF; Shan, BE; Wu, TC; Zhang, SW; Zhu, GJ; Zhu, TN | 1 |
| Beaufrère, H; Brasseur, G; Heimann, M | 1 |
| Ferris, RL; Gooding, W; Hasegawa, H; Seethala, RR; van Waes, C; Wang, J; Zhang, Q | 1 |
| Chen, WL; Wang, YJ; Yang, L; Zeng, SG | 1 |
| Brugarolas, A; Gosalvez, M | 2 |
| Conso, F; Efthymiou, ML; Fournier, E; Garnier, R | 1 |
| McCarty, M | 1 |
| Sappino, AP; Smith, IE | 1 |
| Coninx, P; Galichet, V; Garbe, E; Jardillier, JC; Nasca, S | 1 |
| Croft, WA; Kamiryo, Y; Wang, CY | 1 |
| Crabtree, WN; Matheny, RB; Murphy, WM; Soloway, MS | 1 |
| Betit-Yen, K; Gitterman, CO; Lee, G; Luell, S; Prendergast, JS; Skipski, VP; Stock, CC | 1 |
| Barbieri, A; Boccardo, F; Canobbio, L; Guarneri, D; Merlano, M; Rosso, R | 1 |
| Mickey, DD; Mickey, GH; Murphy, WM; Niell, HB; Soloway, MS | 1 |
| Alberto, P | 1 |
| Kawahara, M; Kayada, Y; Munakata, H; Sakamoto, T; Takada, K; Yoshiga, K | 1 |
| King, WW; Lam, PK; Li, AK | 1 |
| Castro, A; Garozzo, A; Geremia, E; Guerrera, F; Pinizzotto, MR; Tempera, G | 1 |
| Gemba, K; Kiura, K; Matsumura, T; Moritaka, T; Ohnoshi, T; Segawa, Y; Shibayama, T; Tabata, M; Takigawa, N; Ueoka, H | 1 |
| Imamura, T; Kobayashi, M; Morioka, H; Sawa, T; Takada, Y; Takata, Y; Yang, GH | 1 |
| Tan, BK; Wong, KT | 1 |
| Atsumi, T; Hosoi, K; Kurihara, K; Shioda, Y; Sugita, K; Ueha, T | 1 |
| Gao, Y; Guan, WQ; Yu, SF | 1 |
| Jeon, SH; Jin, YJ; Lee, E; Son, YS; Yi, JY | 1 |
| Bancroft, CC; Capo, DE; Chen, Z; Dong, G; Mukaida, N; Sunwoo, JB; Van Waes, C; Wolf, JS; Yeh, NT | 1 |
| Arakawa, T; Fujiwara, Y; Hasuma, T; Higuchi, K; Otani, S; Takashima, T; Yano, Y | 1 |
| Altmann, KH; D'Amico, G; French, CT; Giannakakou, P; Li, J; Liotta, D; Namoto, K; Nicolaou, KC; Ritzén, A; Shoji, M; Ulven, T; Wartmann, M | 1 |
| Goberdhan, A; Hoffman, RM; Li, R; Patel, S; Pfister, D; Poluri, A; Shah, J; Shaha, AR; Sherman, E; Singh, B; Xu, L | 1 |
| Ishihara, S; Kadowaki, Y; Kinoshita, Y; Ortega, C; Rumi, MA; Sato, H | 1 |
| Akita, H; Fijita, H; Haneda, H; Katabami, M; Kawakami, Y; Kuzumaki, N; Miyamoto, H | 1 |
| Keepers, YP; Peters, GJ; Pinedo, HM; Pizao, PE; van Ark-Otte, J; Winograd, B | 1 |
| Day, R; Hata, K; Heo, DS; Herberman, RB; Park, JG; Whiteside, TL | 1 |
| Nagao, M; Ohgaki, H; Sugimura, T; Tahira, T; Wakabayashi, K | 1 |
| Berger, MR; Habs, M; Petru, E; Schmähl, D | 1 |
| Bryan, GT; Cohen, SM; Ertürk, E | 3 |
| Ahl, CA; Daly, JJ; Prout, GR | 1 |
| Del Vecchio, PR; Malmgren, RA; Marrone, JA; Myers, GH; Soloway, MS | 1 |
| Bryan, GT; Cohen, SM; Ertürk, E; Lower, GM | 1 |
| Golub', NI; Linnik, AB | 1 |
| Bryan, GT; Cohen, SM; Ertürk, E; Price, JM | 1 |
| Bryan, GT; Ertürk, E; Yoshida, O | 1 |
3 review(s) available for thiazoles and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Current treatment options for recurrent/metastatic head and neck cancer: a post-ASCO 2011 update and review of last year's literature.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzodioxoles; Carcinoma, Squamous Cell; Cetuximab; Combined Modality Therapy; Dasatinib; ErbB Receptors; Fluorouracil; Gefitinib; Head and Neck Neoplasms; Humans; Indoles; Neoplasm Recurrence, Local; Palliative Care; Pyrimidines; Pyrroles; Quinazolines; Quinazolinones; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Sunitinib; Thiazoles | 2012 |
Promising new targeted agents in head and neck cancer.
Topics: Aurora Kinases; Carcinoma, Squamous Cell; Dasatinib; Enzyme Inhibitors; Focal Adhesion Protein-Tyrosine Kinases; Head and Neck Neoplasms; Humans; Protein Serine-Threonine Kinases; Pyrimidines; Sirolimus; src-Family Kinases; Thiazoles | 2007 |
6 trial(s) available for thiazoles and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Treatment-related toxicities in a phase II trial of dasatinib in patients with squamous cell carcinoma of the lung.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Dasatinib; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Protein Kinase Inhibitors; Pyrimidines; Survival Rate; Thiazoles; Treatment Outcome | 2013 |
Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Child; Cytokines; Dasatinib; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2011 |
The effects of a COX-2 inhibitor meloxicam on squamous cell carcinoma of the esophagus in vivo.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Electrophoretic Mobility Shift Assay; Esophageal Neoplasms; Esophagectomy; Female; Flow Cytometry; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Proteins; Male; Meloxicam; Middle Aged; NF-kappa B; NF-KappaB Inhibitor alpha; Radioimmunoassay; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Thiazines; Thiazoles | 2008 |
Thioproline toxicity.
Topics: Carcinoma, Squamous Cell; Central Nervous System; Humans; Kidney; Thiazoles; Thiazolidines | 1981 |
Preliminary clinical results with norgamem (thioproline) and revercan (2-amino-2-thiazoline): the first inducers of reverse transformation.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Clinical Trials as Topic; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms; Thiazoles; Thiazolidines; Urinary Bladder Neoplasms | 1982 |
118 other study(ies) available for thiazoles and Carcinoma, Epidermoid
| Article | Year |
|---|---|
PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy.
Topics: Aminopyridines; Carcinoma, Squamous Cell; Cell Line, Tumor; Head and Neck Neoplasms; Humans; Morpholines; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Radiation-Sensitizing Agents; Thiazoles | 2021 |
Growth and Viability of Cutaneous Squamous Cell Carcinoma Cell Lines Display Different Sensitivities to Isoform-Specific Phosphoinositide 3-Kinase Inhibitors.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Chromones; Humans; Imidazoles; Isoenzymes; Keratinocytes; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Skin Neoplasms; Thiazoles; Thiazolidinediones; TOR Serine-Threonine Kinases | 2021 |
γ-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma.
Topics: Amyloid Precursor Protein Secretases; Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Proliferation; Diamines; Disease Models, Animal; Head and Neck Neoplasms; Humans; Immunosuppression Therapy; Mice; Mice, Knockout; Myeloid Cells; Protein Serine-Threonine Kinases; PTEN Phosphohydrolase; Receptor, Notch1; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; T-Lymphocytes, Regulatory; Thiazoles; Tumor Cells, Cultured; Tumor Escape | 2018 |
Downregulation of estrogen-related receptor alpha inhibits human cutaneous squamous cell carcinoma cell proliferation and migration by regulating EMT via fibronectin and STAT3 signaling pathways.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Epithelial-Mesenchymal Transition; ERRalpha Estrogen-Related Receptor; Fibronectins; Gene Expression Regulation, Neoplastic; Humans; Nitriles; Receptors, Estrogen; Signal Transduction; Skin Neoplasms; STAT3 Transcription Factor; Thiazoles | 2018 |
Antitumor effects of Dasatinib on laryngeal squamous cell carcinoma in vivo and in vitro.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cisplatin; Dasatinib; Dose-Response Relationship, Drug; Flow Cytometry; Humans; In Vitro Techniques; Laryngeal Neoplasms; Male; Mice; Mice, Nude; Neoplasm Transplantation; Protein Kinase Inhibitors; Pyrimidines; Rats; Thiazoles | 2013 |
Cisplatin enhances the efficacy of 5-aminolevulinic acid mediated photodynamic therapy in human head and neck squamous cell carcinoma.
Topics: Aminolevulinic Acid; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Synergism; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Tetrazolium Salts; Thiazoles; Xenograft Model Antitumor Assays | 2014 |
The HDAC inhibitor, panobinostat, induces apoptosis by suppressing the expresssion of specificity protein 1 in oral squamous cell carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Indoles; Mouth Neoplasms; Panobinostat; Signal Transduction; Sp1 Transcription Factor; Tetrazolium Salts; Thiazoles | 2013 |
Response to dasatinib in a patient with SQCC of the lung harboring a discoid-receptor-2 and synchronous chronic myelogenous leukemia.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Dasatinib; Discoidin Domain Receptors; DNA Mutational Analysis; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Neoplasms; Middle Aged; Mutation, Missense; Neoplasms, Multiple Primary; Pyrimidines; Radiography; Receptor Protein-Tyrosine Kinases; Receptors, Mitogen; Thiazoles; Treatment Outcome | 2013 |
Isoalantolactone inhibits UM-SCC-10A cell growth via cell cycle arrest and apoptosis induction.
Topics: Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cyclin D; Flow Cytometry; G1 Phase Cell Cycle Checkpoints; Head and Neck Neoplasms; Humans; Mitochondria; rho GTP-Binding Proteins; Sesquiterpenes; Tetrazolium Salts; Thiazoles; Tumor Suppressor Protein p53 | 2013 |
Increased killing of SCCVII squamous cell carcinoma cells after the combination of Pc 4 photodynamic therapy and dasatinib is associated with enhanced caspase-3 activity and ceramide synthase 1 upregulation.
Topics: Abdominal Neoplasms; Acid Ceramidase; Amino Acid Chloromethyl Ketones; Animals; Annexin A5; Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Caspase 9; Cell Line, Tumor; Ceramides; Dasatinib; Enzyme Activation; Head and Neck Neoplasms; Indoles; Mice; Mice, Inbred C3H; Mitochondria; Oxidoreductases; Photochemotherapy; Propidium; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; RNA, Messenger; Sphingosine; Thiazoles | 2013 |
Smac mimetic compound LCL161 sensitizes esophageal carcinoma cells to radiotherapy by inhibiting the expression of inhibitor of apoptosis protein.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Biomimetics; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Flow Cytometry; Fluorescent Antibody Technique; Humans; Inhibitor of Apoptosis Proteins; Intracellular Signaling Peptides and Proteins; Mitochondrial Proteins; Radiation-Sensitizing Agents; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles; Ubiquitin-Protein Ligases | 2014 |
Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer lines.
Topics: Antineoplastic Agents; Butadienes; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Chemoradiotherapy; Dasatinib; Drug Screening Assays, Antitumor; Head and Neck Neoplasms; Humans; Imidazoles; Isoxazoles; Leflunomide; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Nitriles; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Radiation Tolerance; STAT5 Transcription Factor; STAT6 Transcription Factor; Thiazoles; Tumor Suppressor Proteins | 2013 |
Characterization of the biological activity of a potent small molecule Hec1 inhibitor TAI-1.
Topics: Adenocarcinoma; Administration, Intravenous; Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cytoskeletal Proteins; Drug Synergism; Female; Gene Knockdown Techniques; Lung Neoplasms; Male; Mice; Mice, Nude; Niacinamide; NIMA-Related Kinases; Nuclear Proteins; Protein Serine-Threonine Kinases; Proteolysis; Retinoblastoma Protein; Thiazoles; Tumor Burden; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2014 |
Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Growth Processes; Cell Line, Tumor; Dasatinib; Drug Synergism; Endoplasmic Reticulum Stress; Female; Head and Neck Neoplasms; Humans; Metformin; Mice; Mice, Nude; Pyrimidines; Squamous Cell Carcinoma of Head and Neck; Thiazoles; Xenograft Model Antitumor Assays | 2014 |
Oct4 mediates tumor initiating properties in oral squamous cell carcinomas through the regulation of epithelial-mesenchymal transition.
Topics: Animals; Carcinogenesis; Carcinoma, Squamous Cell; Cell Line, Tumor; DNA Primers; Epithelial-Mesenchymal Transition; Genetic Vectors; Humans; Mice; Mice, Nude; Mouth Neoplasms; Octamer Transcription Factor-3; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles | 2014 |
Piroxicam inhibits Masitinib-induced cyclooxygenase 2 expression in oral squamous cell carcinoma cells in vitro.
Topics: Animals; Benzamides; Carcinoma, Squamous Cell; Cats; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dogs; Gene Expression Regulation, Enzymologic; Humans; Mouth Neoplasms; Piperidines; Piroxicam; Protein Kinase Inhibitors; Pyridines; Thiazoles | 2014 |
Squamous cell carcinoma of the anal sacs in three dogs.
Topics: Anal Gland Neoplasms; Anal Sacs; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Diagnosis, Differential; Dog Diseases; Dogs; Female; Male; Meloxicam; Thiazines; Thiazoles | 2015 |
Inhibition of SphK1 reduces radiation-induced migration and enhances sensitivity to cetuximab treatment by affecting the EGFR / SphK1 crosstalk.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cetuximab; Disease Progression; ErbB Receptors; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Paraffin Embedding; Phosphotransferases (Alcohol Group Acceptor); Receptor Cross-Talk; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Thiazoles | 2014 |
Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contributes to dasatinib sensitivity via the c-Abl/Ras/ERK pathway.
Topics: Adenocarcinoma; Aged; Animals; Apoptosis; Biomarkers, Tumor; Blotting, Western; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Adhesion; Cell Movement; Cell Proliferation; Dasatinib; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Lung Neoplasms; Mice; Mice, Nude; MicroRNAs; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrimidines; ras Proteins; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma.
Topics: Analysis of Variance; APOBEC-1 Deaminase; Base Sequence; Carcinoma, Squamous Cell; Cell Line, Tumor; China; Class I Phosphatidylinositol 3-Kinases; CREB-Binding Protein; Cytidine Deaminase; DNA Copy Number Variations; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Knockdown Techniques; Genetic Predisposition to Disease; Genome, Human; Humans; Immunoblotting; Immunohistochemistry; In Situ Hybridization, Fluorescence; Ligases; LIM Domain Proteins; Molecular Sequence Data; Mutation; Patched Receptors; Patched-1 Receptor; Phosphatidylinositol 3-Kinases; Polycomb Repressive Complex 1; Polycomb-Group Proteins; Real-Time Polymerase Chain Reaction; Receptors, Cell Surface; Sequence Analysis, DNA; Signal Transduction; Tetrazolium Salts; Thiazoles; Transcription Factors; Tumor Suppressor Proteins; Ubiquitin Thiolesterase; Ubiquitin-Protein Ligases | 2015 |
Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K/AKT and Stat3 pathways.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Dasatinib; Drug Synergism; Esophageal Neoplasms; Human Umbilical Vein Endothelial Cells; Humans; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; STAT3 Transcription Factor; Thiazoles | 2015 |
AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas.
Topics: Animals; Antibodies, Monoclonal, Humanized; Axl Receptor Tyrosine Kinase; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Class I Phosphatidylinositol 3-Kinases; Drug Resistance, Neoplasm; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Head and Neck Neoplasms; Humans; Mice; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase C; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Signal Transduction; Thiazoles; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2015 |
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations.
Topics: Aminopyridines; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Disease Models, Animal; Epithelial-Mesenchymal Transition; Humans; Imidazoles; Lung Neoplasms; Morpholines; Mutation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Quinolines; Signal Transduction; Thiazoles; Xenograft Model Antitumor Assays | 2015 |
Effect of Ocimum sanctum on Oral Cancer Cell Line: An in vitro Study.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromatin; Coloring Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; In Vitro Techniques; Mouth Neoplasms; Ocimum sanctum; Phytotherapy; Plant Extracts; Plant Leaves; Tetrazolium Salts; Thiazoles | 2015 |
Cytotoxic effects of SMAC-mimetic compound LCL161 in head and neck cancer cell lines.
Topics: Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Therapy, Combination; Fas Ligand Protein; fas Receptor; Flow Cytometry; Head and Neck Neoplasms; Humans; Inhibitor of Apoptosis Proteins; Thiazoles | 2016 |
NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Self Renewal; Cisplatin; Diamines; Docetaxel; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Receptor, Notch1; RNA, Small Interfering; Taxoids; Thiazoles; Xenograft Model Antitumor Assays | 2016 |
Luteolin Impacts on the DNA Damage Pathway in Oral Squamous Cell Carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; DNA Damage; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Luteolin; Mouth Neoplasms; Nitro Compounds; Thiazoles; Thioxanthenes; Tyrphostins | 2016 |
Novel Midkine Inhibitor iMDK Inhibits Tumor Growth and Angiogenesis in Oral Squamous Cell Carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Differentiation; Cell Line, Tumor; Coumarins; Cytokines; Female; Humans; Mice; Mice, Inbred BALB C; Midkine; Mouth Neoplasms; Neovascularization, Pathologic; Thiazoles | 2016 |
Notch1 regulates invasion and metastasis of head and neck squamous cell carcinoma by inducing EMT through c-Myc.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antigens, CD; Cadherins; Carcinogenesis; Carcinoma, Squamous Cell; Cell Enlargement; Cell Line, Tumor; Diamines; Epithelial-Mesenchymal Transition; Female; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Mice, Nude; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Prognosis; Proto-Oncogene Proteins c-myc; Receptor, Notch1; Squamous Cell Carcinoma of Head and Neck; Thiazoles; Vimentin; Young Adult | 2017 |
Tumour-specific PI3K inhibition via nanoparticle-targeted delivery in head and neck squamous cell carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Drug Delivery Systems; Head and Neck Neoplasms; Humans; Mice, Nude; Microscopy, Electron, Scanning; Nanoparticles; Protein Kinase Inhibitors; Thiazoles; Treatment Outcome; Xenograft Model Antitumor Assays | 2017 |
A new method to induce multi-drug resistance to carboplatin in a mouse model of human tongue squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Blotting, Western; Carboplatin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Coloring Agents; Disease Models, Animal; DNA Topoisomerases, Type II; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glutathione Transferase; Humans; Immunohistochemistry; Injections, Intradermal; Mice; Mice, Inbred BALB C; Mice, Nude; Multidrug Resistance-Associated Proteins; Neoplasm Transplantation; Reverse Transcriptase Polymerase Chain Reaction; Skin Neoplasms; Tetrazolium Salts; Thiazoles; Tongue Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured | 2008 |
A selective cyclooxygenase-2 inhibitor prevents inflammation-related squamous cell carcinogenesis of the forestomach via duodenogastric reflux in rats.
Topics: Animals; Carcinoma, Squamous Cell; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Duodenogastric Reflux; Immunohistochemistry; Inflammation; Male; Meloxicam; Random Allocation; Rats; Rats, Inbred F344; Stomach Neoplasms; Thiazines; Thiazoles | 2009 |
Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dasatinib; Head and Neck Neoplasms; Humans; Janus Kinase 2; Mice; Phosphorylation; Pyrimidines; src-Family Kinases; STAT3 Transcription Factor; Thiazoles; TYK2 Kinase | 2009 |
Inhibition of cyclooxygenase-2 suppresses the invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 production and activation.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Collagen; Cyclooxygenase 2 Inhibitors; Down-Regulation; Drug Combinations; Enzyme Activation; Fibroblasts; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Laminin; Matrix Metalloproteinase 2; Mouth Neoplasms; Neoplasm Invasiveness; Proteoglycans; Tetrazolium Salts; Thiazoles; Tissue Inhibitor of Metalloproteinase-2 | 2009 |
Non-genomic inhibitory signaling of beta-carotene in squamous cell carcinoma of the lungs.
Topics: beta Carotene; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Gene Expression Regulation, Neoplastic; Humans; Immunoassay; Lung Neoplasms; Models, Biological; Phosphorylation; Signal Transduction; Tetrazolium Salts; Thiazoles; Time Factors | 2009 |
The Na+/K+-ATPase is the Achilles heel of multi-drug-resistant cancer cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cardenolides; Cell Line, Tumor; Cell Survival; Drug Resistance, Multiple; HeLa Cells; Humans; Hydroxyurea; Ligands; Neoplasms; Sodium-Potassium-Exchanging ATPase; Thiazoles | 2009 |
The natural diterpenoid ovatodiolide induces cell cycle arrest and apoptosis in human oral squamous cell carcinoma Ca9-22 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Caspases; Cell Cycle; Cell Line, Tumor; Cell Survival; Diterpenes; Enzyme Activation; Genes, p53; Humans; Mouth Neoplasms; Oxidative Stress; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles | 2009 |
Expression of CXCR4 in oral squamous cell carcinoma: correlations with clinicopathology and pivotal role of proliferation.
Topics: Adult; Aged; Antibodies, Monoclonal; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL12; Coloring Agents; Female; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Receptors, CXCR4; Tetrazolium Salts; Thiazoles; Time Factors | 2010 |
PTEN/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells.
Topics: Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Neoplasm Proteins; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Thiazoles; Tongue Neoplasms | 2009 |
Mammalian target of rapamycin (mTOR) is involved in the survival of cells mediated by chemokine receptor 7 through PI3K/Akt in metastatic squamous cell carcinoma of the head and neck.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Survival; Chemokine CCL19; Chromones; Cisplatin; Coloring Agents; Enzyme Inhibitors; Flow Cytometry; Head and Neck Neoplasms; Humans; Intracellular Signaling Peptides and Proteins; Morpholines; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Polymerase Chain Reaction; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Receptors, CCR7; Ribosomal Protein S6 Kinases, 70-kDa; Sirolimus; Tetrazolium Salts; Thiazoles; TOR Serine-Threonine Kinases | 2010 |
Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Dinoprostone; Disease Models, Animal; Female; Keratinocytes; Keratins; Keratoacanthoma; Ligands; Mice; Mice, Inbred C57BL; Mice, Knockout; Papilloma; PPAR delta; PPAR-beta; RNA, Messenger; Skin Neoplasms; Sulfonamides; Thiazoles; Time Factors | 2010 |
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cetuximab; Combined Modality Therapy; Dasatinib; Ear Diseases; Fusion Proteins, bcr-abl; Humans; Keratoacanthoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Neoplasms, Second Primary; Pyrimidines; Radiotherapy; Scalp; Thiazoles; Tongue Neoplasms; Vocal Cords | 2010 |
Antimetastatic effects of Terminalia catappa L. on oral cancer via a down-regulation of metastasis-associated proteases.
Topics: Anticarcinogenic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Migration Assays; Cell Movement; Cell Survival; Down-Regulation; Drug Screening Assays, Antitumor; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Peptide Hydrolases; Plant Extracts; Terminalia; Tetrazolium Salts; Thiazoles; Tongue Neoplasms | 2010 |
Targeting polo-like kinase 1 enhances radiation efficacy for head-and-neck squamous cell carcinoma.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Caspase 7; Cell Cycle Proteins; Cell Line, Tumor; Cyclin B1; Cyclin-Dependent Kinase Inhibitor p21; Female; Head and Neck Neoplasms; Histones; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; RNA, Messenger; RNA, Small Interfering; Tetrazolium Salts; Thiazoles; Transfection; Tumor Stem Cell Assay | 2010 |
Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinoma.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Dasatinib; ErbB Receptors; Head and Neck Neoplasms; Humans; Neoplasms, Squamous Cell; Protein Kinase Inhibitors; Protein Transport; Pyrimidines; Squamous Cell Carcinoma of Head and Neck; Thiazoles | 2010 |
Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition.
Topics: Animals; Apoptosis; Blotting, Western; Carcinoma; Carcinoma, Squamous Cell; Disease Models, Animal; Enzyme Inhibitors; Head and Neck Neoplasms; Humans; Immunohistochemistry; In Vitro Techniques; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Squamous Cell; Phosphotransferases (Alcohol Group Acceptor); Polymerase Chain Reaction; Radiation Tolerance; Squamous Cell Carcinoma of Head and Neck; Thiazoles; Treatment Outcome | 2011 |
Distinct interactions between c-Src and c-Met in mediating resistance to c-Src inhibition in head and neck cancer.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Survival; Crizotinib; CSK Tyrosine-Protein Kinase; Dasatinib; Drug Interactions; Drug Resistance, Neoplasm; Humans; Mice; Mice, Nude; Mouth Neoplasms; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-met; Pyrazoles; Pyridines; Pyrimidines; src-Family Kinases; Thiazoles | 2011 |
The effect of coptis chinensis on the signaling network in the squamous carcinoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Berberine; Blotting, Western; Carcinoma, Squamous Cell; Cell Adhesion; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Computational Biology; Coptis; Cytoskeletal Proteins; Humans; Mice; Mice, Nude; Plant Extracts; Signal Transduction; Tetrazolium Salts; Thiazoles | 2011 |
Effect of curcumin and irradiation in PE/CA-PJ15 oral squamous cell carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Colorimetry; Coloring Agents; Curcumin; Humans; Mouth Neoplasms; Neoadjuvant Therapy; Radiation-Sensitizing Agents; Radiotherapy Dosage; Tetrazolium Salts; Thiazoles; Time Factors | 2011 |
S100A4 mediated cell invasion and metastasis of esophageal squamous cell carcinoma via the regulation of MMP-2 and E-cadherin activity.
Topics: Blotting, Western; Cadherins; Carcinoma, Squamous Cell; DNA Primers; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Neoplasm Metastasis; Real-Time Polymerase Chain Reaction; S100 Calcium-Binding Protein A4; S100 Proteins; Tetrazolium Salts; Thiazoles | 2012 |
Inhibition of cell growth and up-regulation of MAD2 in human oesophageal squamous cell carcinoma after treatment with the Src/Abl inhibitor dasatinib.
Topics: Animals; Antineoplastic Agents; Apoptosis; Calcium-Binding Proteins; Carcinoma, Squamous Cell; Cell Cycle; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Cell Proliferation; Dasatinib; Docetaxel; Drug Synergism; Esophageal Neoplasms; Female; Humans; Mad2 Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrimidines; Repressor Proteins; src-Family Kinases; Taxoids; Thiazoles; Up-Regulation; Xenograft Model Antitumor Assays | 2012 |
The expression and significance of MRP1, LRP, TOPOIIβ, and BCL2 in tongue squamous cell carcinoma.
Topics: Antineoplastic Agents; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Shape; Cisplatin; Coloring Agents; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Fluorescent Antibody Technique; Humans; Lymphatic Metastasis; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Grading; Neoplasm Staging; Proto-Oncogene Proteins c-bcl-2; Tetrazolium Salts; Thiazoles; Tongue; Tongue Neoplasms; Vault Ribonucleoprotein Particles | 2012 |
The role of focal adhesion kinase catalytic activity on the proliferation and migration of squamous cell carcinoma cells.
Topics: Animals; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Polarity; Cell Proliferation; Dasatinib; Focal Adhesion Protein-Tyrosine Kinases; Indoles; Mice; Mice, Transgenic; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; src-Family Kinases; Sulfonamides; Thiazoles | 2012 |
The multidrug resistant modulator HZ08 reverses multidrug resistance via P-glycoprotein inhibition and apoptosis sensitization in human epidermoid carcinoma cell line KBV200.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; bcl-2-Associated X Protein; Blotting, Western; Carcinoma, Squamous Cell; Caspase 3; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Isoquinolines; KB Cells; Proto-Oncogene Proteins c-bcl-2; Tetrazolium Salts; Thiazoles | 2012 |
Lyn kinase mediates cell motility and tumor growth in EGFRvIII-expressing head and neck cancer.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; CSK Tyrosine-Protein Kinase; Dasatinib; Disease Progression; ErbB Receptors; Head and Neck Neoplasms; Humans; Immunoprecipitation; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-yes; Pyrimidines; Random Allocation; RNA Interference; RNA, Small Interfering; Squamous Cell Carcinoma of Head and Neck; src-Family Kinases; Thiazoles; Transplantation, Heterologous | 2012 |
Degradation of epidermal growth factor receptor mediates dasatinib-induced apoptosis in head and neck squamous cell carcinoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Dasatinib; Drug Resistance, Neoplasm; ErbB Receptors; Estrogen Receptor alpha; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Inhibitory Concentration 50; Lysosomes; Male; Mice; Mice, Nude; Protein Kinase Inhibitors; Proteolysis; Proto-Oncogene Proteins c-akt; Pyrimidines; src-Family Kinases; Thiazoles; Xenograft Model Antitumor Assays | 2012 |
The effects of 5-fluorouracil alone and in combination with 13-cis retinoic acid and vitamin D3 on human oral squamous cell carcinoma lines.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cholecalciferol; Drug Combinations; Drug Synergism; Fluorouracil; Humans; In Situ Nick-End Labeling; Isotretinoin; Mouth Neoplasms; Tetrazolium Salts; Thiazoles | 2012 |
Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways.
Topics: Active Transport, Cell Nucleus; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Nucleus; CSK Tyrosine-Protein Kinase; Dasatinib; DNA Repair; ErbB Receptors; Focal Adhesion Protein-Tyrosine Kinases; Head and Neck Neoplasms; Humans; Protein Kinase Inhibitors; Pyrimidines; Radiation Tolerance; Squamous Cell Carcinoma of Head and Neck; src-Family Kinases; Thiazoles | 2012 |
Initial attachment, subsequent cell proliferation/viability and gene expression of epithelial cells related to attachment and wound healing in response to different titanium surfaces.
Topics: Acid Etching, Dental; Carcinoma, Squamous Cell; Cell Adhesion; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Coloring Agents; Dental Etching; Dental Implants; Dental Materials; Epithelial Cells; Gene Expression Regulation; Humans; Hydrophobic and Hydrophilic Interactions; Integrin alpha6; Integrin beta4; Keratin-14; Membrane Proteins; Mouth Mucosa; Mouth Neoplasms; Surface Properties; Tetrazolium Salts; Thiazoles; Titanium; Transforming Growth Factor beta; Vinculin; Wound Healing | 2012 |
Does LLLT stimulate laryngeal carcinoma cells? An in vitro study.
Topics: Analysis of Variance; Carcinoma, Squamous Cell; Cell Division; Cell Survival; Coloring Agents; Dose-Response Relationship, Radiation; Humans; Laryngeal Neoplasms; Low-Level Light Therapy; Optics and Photonics; Radiation Dosage; Spectrum Analysis; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2002 |
15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells.
Topics: Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; DNA Primers; DNA-Binding Proteins; Down-Regulation; Humans; Immunoenzyme Techniques; Immunologic Factors; Mouth Neoplasms; Phosphorylation; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; STAT3 Transcription Factor; Thiazoles; Thiazolidinediones; Trans-Activators; Transcription Factors; Tumor Cells, Cultured | 2002 |
Microsomal prostaglandin E synthase-1 is overexpressed in head and neck squamous cell carcinoma.
Topics: Blotting, Western; Carcinoma, Squamous Cell; Cell Line; Cell Transformation, Neoplastic; Coloring Agents; Head and Neck Neoplasms; Humans; Immunoblotting; Immunohistochemistry; Intramolecular Oxidoreductases; Microsomes; Mucous Membrane; Prognosis; Prostaglandin-E Synthases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Thiazoles; Time Factors | 2003 |
Apoptosis in human oral squamous cell carcinomas is induced by 15-deoxy-delta 12,14-prostaglandin J2 but not by troglitazone.
Topics: Amino Acid Chloromethyl Ketones; Analysis of Variance; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Caspase Inhibitors; Caspases; Cell Survival; Chromans; Cysteine Proteinase Inhibitors; Cytochrome c Group; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Immunologic Factors; Mouth Neoplasms; Oligopeptides; Prostaglandin D2; Signal Transduction; Thiazoles; Thiazolidinediones; Time Factors; Troglitazone; Tumor Cells, Cultured | 2003 |
Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Western; Carcinoma, Squamous Cell; Cell Division; Cell Line, Tumor; Coloring Agents; DNA-Binding Proteins; Docetaxel; Dose-Response Relationship, Drug; Down-Regulation; ErbB Receptors; Female; Head and Neck Neoplasms; Humans; Inhibitory Concentration 50; Mice; Mice, Nude; Neoplasm Transplantation; Oligonucleotides, Antisense; Phosphotyrosine; Signal Transduction; STAT3 Transcription Factor; Taxoids; Tetrazolium Salts; Thiazoles; Time Factors; Trans-Activators; Vascular Endothelial Growth Factor A | 2003 |
3-OH flavone inhibition of epidermal growth factor-induced proliferaton through blocking prostaglandin E2 production.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Cell Division; Colony-Forming Units Assay; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Activation; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Flavonoids; Gene Expression Regulation, Enzymologic; Humans; Isoenzymes; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Membrane Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Prostaglandin-Endoperoxide Synthases; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2004 |
Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Barrett Esophagus; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Diet; Duodenogastric Reflux; Duodenum; Epithelium; Esophageal Neoplasms; Immunoenzyme Techniques; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroso Compounds; Peroxynitrous Acid; Rats; Rats, Wistar; Reactive Nitrogen Species; Thiazoles; Thiazolidines | 2004 |
The relationship of the human glutathione S-transferase P1 polymorphism and chemotherapeutic sensitivity in head and neck squamous carcinoma.
Topics: Alleles; Antineoplastic Agents; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Multiple; Exons; Genotype; Glutathione Transferase; Head and Neck Neoplasms; Heterozygote; Humans; Inhibitory Concentration 50; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Analysis, DNA; Tetrazolium Salts; Thiazoles; Valine | 2004 |
Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Division; Cell Line, Tumor; Ceramides; Chromatography, Liquid; Coloring Agents; DNA, Complementary; Head and Neck Neoplasms; Humans; Mass Spectrometry; Membrane Potentials; Membrane Proteins; Mice; Mitochondria; Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Saccharomyces cerevisiae Proteins; Sphingosine N-Acyltransferase; Telomerase; Tetrazolium Salts; Thiazoles; Trypan Blue | 2004 |
In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cells.
Topics: Apoptosis; bcl-X Protein; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dimerization; Dose-Response Relationship, Drug; Drug Resistance; Fibroblasts; Gossypol; Head and Neck Neoplasms; Humans; In Situ Nick-End Labeling; Inhibitory Concentration 50; Peptide Fragments; Protein Structure, Tertiary; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Suppressor Protein p53 | 2004 |
Establishment and gene analysis of a cisplatin-resistant cell line, Sa-3R, derived from oral squamous cell carcinoma.
Topics: Biopsy; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; Coloring Agents; DNA, Complementary; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Male; Mouth Neoplasms; Multidrug Resistance-Associated Protein 2; Oligonucleotide Array Sequence Analysis; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Thiazoles; Time Factors; Up-Regulation | 2005 |
Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Adenosquamous; Carcinoma, Ductal; Carcinoma, Squamous Cell; Cell Differentiation; Disease Progression; Female; Gene Expression Profiling; Mammary Neoplasms, Experimental; Mice; Oxazoles; PPAR delta; PPAR gamma; Thiazoles; Tyrosine | 2005 |
Curcumin suppresses growth of head and neck squamous cell carcinoma.
Topics: Animals; Annexin A5; Antineoplastic Agents; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Nucleus; Cell Separation; Cell Survival; Curcumin; Cyclin D1; Dose-Response Relationship, Drug; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; I-kappa B Proteins; In Vitro Techniques; Mice; Mice, Nude; Microscopy, Fluorescence; Neoplasm Transplantation; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Tetrazolium Salts; Thiazoles | 2005 |
Expression of dihydrodiol dehydrogenase plays important roles in apoptosis- and drug-resistance of A431 squamous cell carcinoma.
Topics: Apoptosis; Bleomycin; Carcinoma, Squamous Cell; Caspase 3; Caspases; Cell Line; Cell Line, Tumor; Disease Progression; Drug Resistance, Neoplasm; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; In Situ Nick-End Labeling; Keratinocytes; Models, Statistical; Oxidoreductases; Polycyclic Aromatic Hydrocarbons; Prognosis; RNA Interference; Skin Neoplasms; Tetrazolium Salts; Thiazoles; Ultraviolet Rays; Up-Regulation | 2006 |
In vitro effects of nitric oxide synthase inhibitor L-NAME on oral squamous cell carcinoma: a preliminary study.
Topics: Acridine Orange; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Coloring Agents; DNA; Dose-Response Relationship, Drug; Down-Regulation; Endothelium, Vascular; Enzyme Inhibitors; Fluorescent Dyes; Gentian Violet; Humans; In Situ Hybridization; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrous Oxide; RNA; Tetrazolium Salts; Thiazoles; Tongue Neoplasms; Tumor Cells, Cultured | 2006 |
Effect of dendritic cell vaccine against a tongue squamous cell cancer cell line (Tca8113) in vivo and in vitro.
Topics: Animals; Cancer Vaccines; Carcinoma, Squamous Cell; Cell Line, Tumor; Coloring Agents; Dendritic Cells; Disease Models, Animal; Disease Progression; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunophenotyping; Interleukin-4; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; T-Lymphocytes; Tetrazolium Salts; Thiazoles; Tongue Neoplasms; Tumor Necrosis Factor-alpha | 2006 |
Epidermal growth factor induction of resistance to topoisomerase II toxins in human squamous carcinoma A431 cells.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; DNA Topoisomerases, Type II; Down-Regulation; Drug Resistance, Neoplasm; Epidermal Growth Factor; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Oligonucleotides; Phosphorylation; Tetrazolium Salts; Thiazoles; Tyrosine | 2006 |
Interleukin-12 expression enhances vesicular stomatitis virus oncolytic therapy in murine squamous cell carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Coloring Agents; Disease Models, Animal; Gene Expression Regulation, Viral; Gene Transfer Techniques; Genetic Vectors; Injections, Intralesional; Interleukin-12; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Mouth Floor; Mouth Neoplasms; Oncolytic Virotherapy; Oncolytic Viruses; RNA, Viral; Survival Rate; Tetrazolium Salts; Thiazoles; Vesicular stomatitis Indiana virus; Virus Replication | 2007 |
What is your diagnosis? Squamous cell carcinoma of the uropygial gland.
Topics: Animals; Anti-Infective Agents, Local; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Bird Diseases; Carcinoma, Squamous Cell; Chlorhexidine; Diagnosis, Differential; Enrofloxacin; Female; Fluoroquinolones; Immunohistochemistry; Meloxicam; Parrots; Sebaceous Gland Neoplasms; Thiazines; Thiazoles; Treatment Outcome | 2007 |
Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Apoptosis; Autocrine Communication; Biomarkers, Tumor; Carcinoma, Squamous Cell; Chemokine CCL19; Chemokine CCL21; Cisplatin; Disease Models, Animal; Disease Progression; ErbB Receptors; Female; Formazans; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Mice; Middle Aged; Paracrine Communication; Receptors, CCR7; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Tetrazolium Salts; Thiazoles; Up-Regulation | 2008 |
Effect of using RNA interference to alter iNOS gene expression on the proliferation of tongue squamous cell carcinoma cell line Tca8113.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Coloring Agents; Flow Cytometry; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gene Silencing; Histocytochemistry; Humans; Indicators and Reagents; Lipids; Nitric Oxide; Nitric Oxide Synthase Type II; Plasmids; RNA Interference; RNA, Small Interfering; Tetrazolium Salts; Thiazoles; Tongue Neoplasms; Transfection | 2008 |
Treatment of cancer by an inducer of reverse transformation.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Carboxylic Acids; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Neoplasms; Thiazoles; Thiazolidines | 1980 |
Thioproline.
Topics: Adult; Antineoplastic Agents; Biotransformation; Carcinoma, Squamous Cell; Child; Child, Preschool; Humans; Infant; Status Epilepticus; Thiazoles | 1980 |
Thioproline.
Topics: Benzaldehydes; Carcinoma, Squamous Cell; Humans; Thiazoles | 1980 |
Thioproline in squamous cell cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Psychoses, Substance-Induced; Thiazoles; Thiazolidines | 1980 |
Carcinogenicity of 2-amino-4-(5-nitro-2-furyl) thiazole in rats by oral and subcutaneous administration.
Topics: Animals; Body Weight; Carcinogens; Carcinoma, Squamous Cell; Diet; FANFT; Female; Histiocytoma, Benign Fibrous; Injections, Subcutaneous; Male; Neoplasms, Experimental; Rats; Skin Neoplasms; Stomach Neoplasms; Thiazoles; Urologic Neoplasms | 1982 |
Metastatic characteristics of four FANFT-induced murine bladder tumors.
Topics: Animals; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; FANFT; Lung Neoplasms; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Thiazoles; Urinary Bladder Neoplasms | 1983 |
Possible relationship between glycosphingolipids and the formation of metastasis in certain human experimental tumors.
Topics: Animals; Carcinoma, Squamous Cell; Chick Embryo; Gangliosides; Glycosphingolipids; Humans; Neoplasm Metastasis; Neoplasms, Experimental; Quinazolines; Sarcoma; Thiazoles | 1980 |
Phase II trial of thioproline in advanced epidermoid head and neck tumors.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nervous System Diseases; Thiazoles; Thiazolidines | 1982 |
In vitro characterization of four N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide (FANFT) induced mouse bladder tumors.
Topics: Animals; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cell Line; FANFT; Karyotyping; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Thiazoles; Urinary Bladder Neoplasms | 1982 |
Thioproline (Norgamem): a useless drug in the treatment of squamous cell carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Evaluation; Head and Neck Neoplasms; Humans; Lung Neoplasms; Thiazoles; Thiazolidines | 1981 |
A biochemical evaluation of oral squamous cell carcinoma growth by measurement of specific activity of succinate dehydrogenase in the subrenal capsule assay.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Colorimetry; Coloring Agents; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; Neoplasm Transplantation; Peplomycin; Regression Analysis; Subrenal Capsule Assay; Succinate Dehydrogenase; Tetrazolium Salts; Thiazoles | 1995 |
Anti-proliferative activity of interferon-alpha on human squamous carcinoma of tongue cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Division; Cell Survival; Cisplatin; Combined Modality Therapy; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Interferon Type I; Kinetics; Recombinant Proteins; Tetrazolium Salts; Thiazoles; Tongue Neoplasms; Tumor Cells, Cultured | 1994 |
Antipoliovirus activity of isothiazole derivatives: mode of action of 5,5'-diphenyl-3,3'-diisothiazole disulfide (DID).
Topics: Antiviral Agents; Capsid; Carcinoma, Squamous Cell; Cell Line; Disulfides; DNA-Directed RNA Polymerases; Humans; Kinetics; Molecular Structure; Poliovirus; Receptors, Virus; RNA, Viral; Thiazoles; Tumor Cells, Cultured; Viral Plaque Assay; Virus Replication | 1994 |
[In vitro comparison of podophyllotoxin analogues; etoposide, teniposide and NK 611 using human lung cancer cell lines].
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Division; Drug Resistance; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Podophyllotoxin; Teniposide; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1993 |
Pioglitazone attenuates the inhibitory effect of phorbol ester on epidermal growth factor receptor autophosphorylation and tyrosine kinase activity.
Topics: Carcinoma, Squamous Cell; ErbB Receptors; Humans; Hypoglycemic Agents; Phosphorylation; Pioglitazone; Protein Kinase C; Protein Tyrosine Phosphatases; Receptor Protein-Tyrosine Kinases; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Tumor Cells, Cultured | 1996 |
In vitro cytotoxicity and immunomodulating property of Rhaphidophora korthalsii.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Division; Colonic Neoplasms; Coloring Agents; Concanavalin A; Dose-Response Relationship, Drug; Female; Humans; Leukemia; Leukemia P388; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Nasopharyngeal Neoplasms; Plant Extracts; Plant Lectins; Plants, Medicinal; Spleen; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Water | 1996 |
ATP- and EGF-stimulated phosphatidulinositol synthesis by two different pathways, phospholipase D and diacylglycerol kinase, in A-431 epidermoid carcinoma cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Bradykinin; Calcimycin; Calcium; Carcinoma, Squamous Cell; Chelating Agents; Choline; Diacylglycerol Kinase; Egtazic Acid; Enzyme Activation; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Humans; Ionophores; Neoplasm Proteins; Pertussis Toxin; Phosphatidic Acids; Phosphatidylinositol Diacylglycerol-Lyase; Phosphatidylinositols; Phospholipase D; Phosphotransferases (Alcohol Group Acceptor); Pyrimidinones; Receptors, Purinergic P2; Signal Transduction; Staurosporine; Sulfonamides; Thiazoles; Tumor Cells, Cultured; Type C Phospholipases; Virulence Factors, Bordetella | 1996 |
Alteration of Fas/FasL expression of oral squamous cell carcinoma cell line Tca83 induced by retinoic acid.
Topics: Antigens, Surface; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Division; Cell Survival; Coloring Agents; Fas Ligand Protein; fas Receptor; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Ligands; Membrane Glycoproteins; Protein Biosynthesis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Thiazoles; Time Factors; Tongue Neoplasms; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured; Up-Regulation | 2000 |
Calcipotriol inhibits autocrine phosphorylation of EGF receptor in a calcium-dependent manner, a possible mechanism for its inhibition of cell proliferation and stimulation of cell differentiation.
Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Antineoplastic Agents; Apoptosis; Autocrine Communication; Blotting, Western; Bromodeoxyuridine; Calcitriol; Calcium; Carcinoma, Squamous Cell; Cell Differentiation; Cell Division; Cell Line; ErbB Receptors; Fluorescent Dyes; Humans; Keratinocytes; Phosphorylation; Proliferating Cell Nuclear Antigen; Protein Precursors; Proteins; Shc Signaling Adaptor Proteins; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; Tetrazolium Salts; Thiazoles | 2001 |
IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas.
Topics: Carcinoma, Squamous Cell; Cell Division; Cell Survival; Coloring Agents; Enzyme-Linked Immunosorbent Assay; Genes, Reporter; Genetic Vectors; Head and Neck Neoplasms; Humans; Interleukin-1; Interleukin-8; Mutation; NF-kappa B; Plasmids; Recombinant Proteins; Tetrazolium Salts; Thiazoles; Time Factors; Transcription Factor AP-1; Transcriptional Activation; Transfection; Tumor Cells, Cultured | 2001 |
PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Chromans; DNA Primers; Esophageal Neoplasms; Flow Cytometry; Humans; Immunologic Factors; Ligands; Ornithine Decarboxylase; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Thiazoles; Thiazolidinediones; Thymidine; Transcription Factors; Troglitazone; Tumor Cells, Cultured | 2001 |
Chemical synthesis and biological evaluation of cis- and trans-12,13-cyclopropyl and 12,13-cyclobutyl epothilones and related pyridine side chain analogues.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Screening Assays, Antitumor; Epoxy Compounds; Female; Humans; Ovarian Neoplasms; Pyridines; Thiazoles; Tubulin; Tumor Cells, Cultured | 2001 |
Prediction of survival in patients with head and neck cancer using the histoculture drug response assay.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Survival; Cisplatin; Drug Monitoring; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Survival Rate; Tetrazolium Salts; Thiazoles; Time Factors; Treatment Outcome | 2002 |
Growth inhibition of esophageal squamous carcinoma cells by peroxisome proliferator-activated receptor-gamma ligands.
Topics: Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Chromans; DNA Replication; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Ligands; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Troglitazone; Tumor Cells, Cultured | 2002 |
Reduced drug accumulation in a newly established human lung squamous-carcinoma cell line resistant to cis-diamminedichloroplatinum(II).
Topics: Carcinoma, Squamous Cell; Cell Division; Cell Line; Cisplatin; Drug Resistance; Humans; Lung Neoplasms; Platinum; Tetrazolium Salts; Thiazoles | 1992 |
Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing.
Topics: Calorimetry; Carcinoma, Squamous Cell; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Head and Neck Neoplasms; Humans; Rhodamines; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1991 |
Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity.
Topics: Carcinoma, Squamous Cell; Cell Adhesion; Cell Count; Cell Survival; Chromium Radioisotopes; Colorimetry; Evaluation Studies as Topic; Head and Neck Neoplasms; Humans; Immunity, Cellular; Killer Cells, Lymphokine-Activated; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured | 1990 |
The inhibitory effect of thioproline on carcinogenesis induced by N-benzylmethylamine and nitrite.
Topics: Animals; Benzylamines; Carcinoma, Squamous Cell; Male; Nitrites; Rats; Rats, Inbred F344; Stomach Neoplasms; Thiazoles; Thiazolidines | 1988 |
Influence of the application mode of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide on the localization of its carcinogenic expression in female NMRI-mice.
Topics: Adenocarcinoma; Administration, Oral; Animals; Carcinoma, Squamous Cell; FANFT; Female; Mice; Mice, Inbred Strains; Papilloma; Stomach Neoplasms; Thiazoles; Urinary Bladder Neoplasms | 1986 |
Carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl] acetamide in female rats.
Topics: Acetamides; Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adenofibroma; Animals; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemical Phenomena; Chemistry; Female; Fibroma; Fibrosarcoma; Intestinal Neoplasms; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma, Non-Hodgkin; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Nitrofurans; Rats; Salivary Gland Neoplasms; Skin Neoplasms; Splenic Neoplasms; Thiazoles; Time Factors; Transplantation, Homologous | 1970 |
Carcinogenicity of formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]-hydrazide in Swiss mice.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Animals; Body Weight; Carcinogens; Carcinoma, Squamous Cell; Diet; Female; Formates; Hydrazines; Leukemia, Experimental; Liver Neoplasms; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Nitrofurans; Skin Neoplasms; Stomach Neoplasms; Thiazoles; Uterine Neoplasms | 1970 |
Demonstration of specific antigen in N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide induced rat bladder tumor.
Topics: Adenocarcinoma; Animals; Antigens, Neoplasm; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Culture Techniques; Cytotoxicity Tests, Immunologic; Female; Formamides; Histocompatibility Antigens; Immunodiffusion; Isoenzymes; Karyotyping; L-Lactate Dehydrogenase; Neoplasm Transplantation; Neoplasms, Experimental; Nitrofurans; Parabiosis; Rats; Thiazoles; Urinary Bladder Neoplasms | 1973 |
Evaluation of urinary cytology as an indicator of bladder neoplasia in mice.
Topics: Animals; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Erythrocytes; Female; Formamides; Hematuria; Mice; Neoplasms, Experimental; Nitrofurans; Thiazoles; Urinary Bladder Neoplasms; Urine | 1973 |
Comparative carcinogenicity in Swiss mice of N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide and structurally related 5-nitrofurans and 4-nitrobenzenes.
Topics: Acetamides; Animals; Carcinogens; Carcinoma, Squamous Cell; Female; Formamides; Leukemia, Experimental; Leukemia, Lymphoid; Mice; Neoplasms, Experimental; Nitrobenzenes; Nitrofurans; Papilloma; Stomach Neoplasms; Structure-Activity Relationship; Thiazoles; Thioacetamide; Urinary Bladder Neoplasms | 1973 |
[On the blastomogenic activity of phenanthrothiazoles].
Topics: Adenoma; Animals; Carcinogens; Carcinoma, Squamous Cell; Female; Lung Neoplasms; Male; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Papilloma; Sarcoma, Experimental; Sebaceous Gland Neoplasms; Skin Neoplasms; Thiazoles | 1969 |
Pathogenesis, histology, and transplantability of urinary bladder carcinomas induced in albino rats by oral administration of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.
Topics: Amides; Animals; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Hyperplasia; Male; Neoplasm Transplantation; Nitrofurans; Rats; Thiazoles; Time Factors; Urinary Bladder Neoplasms | 1969 |
Production of urinary bladder carcinomas in mice by sodium saccharin.
Topics: Animals; Carcinoma, Squamous Cell; Cholesterol; Mice; Saccharin; Sweetening Agents; Thiazoles; Time Factors; Urinary Bladder Neoplasms | 1970 |
Production of leukemia and stomach neoplasms in Swiss, RF, BALB-c, and C3H female mice by feeding N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide.
Topics: Acetates; Adenoma; Amides; Animals; Anti-Bacterial Agents; Carcinogens; Carcinoma, Squamous Cell; Diet; Female; Leukemia, Experimental; Leukemia, Lymphoid; Lung Neoplasms; Mice; Neoplasms, Experimental; Nitrofurans; Species Specificity; Stomach Neoplasms; Thiazoles | 1970 |